Sensydia Corporation is a Los Angeles-based company that specializes in developing and providing advanced hemodynamic measurement solutions for cardiovascular and critical patient care. Their flagship product, the Sensydia Cardiac Performance System (CPS), offers accurate and non-invasive measurements equivalent to gold-standard measures, enabling rapid assessment of key metrics such as Ejection Fraction (EF), Cardiac Output (CO), and Pulmonary Artery Pressure (PAP). With the mission to advance care for heart failure, sepsis, and other critical cardiovascular conditions, Sensydia aims to make these vital measures widely available to hospitals and clinics.
The CPS platform is designed to be user-friendly, allowing for easy deployment in various healthcare settings, including hospitals, ICUs, emergency rooms, and medical offices. By providing real-time, objective, and informed decisions, CPS helps improve patient outcomes, reduce readmissions, and lower costs. Additionally, the system can be used over telemedicine, enabling remote hemodynamic monitoring without exposing patients to unnecessary risks, especially those with heart and pulmonary conditions. Sensydia Corporation is committed to revolutionizing hemodynamic measurement and advancing cardiovascular care through their innovative CPS platform.
Generated from the website